142 related articles for article (PubMed ID: 29771765)
1. Comparison of Fasting Human Pancreatic Polypeptide Levels Among Patients With Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, and Type 2 Diabetes Mellitus.
Nagpal SJS; Bamlet WR; Kudva YC; Chari ST
Pancreas; 2018 Jul; 47(6):738-741. PubMed ID: 29771765
[TBL] [Abstract][Full Text] [Related]
2. A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes.
Hart PA; Kudva YC; Yadav D; Andersen DK; Li Y; Toledo FGS; Wang F; Bellin MD; Bradley D; Brand RE; Cusi K; Fisher W; Mather K; Park WG; Saeed Z; Considine RV; Graham SC; Rinaudo JA; Serrano J; Goodarzi MO
J Clin Endocrinol Metab; 2023 Apr; 108(5):e120-e128. PubMed ID: 36404274
[TBL] [Abstract][Full Text] [Related]
3. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
[TBL] [Abstract][Full Text] [Related]
4. Can plasma human pancreatic polypeptide be used to detect diseases of the exocrine pancreas?
Koch MB; Go VL; DiMagno EP
Mayo Clin Proc; 1985 Apr; 60(4):259-65. PubMed ID: 2984484
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.
Rychlíková J; Vecka M; Jáchymová M; Macášek J; Hrabák P; Zeman M; Vávrová L; Řoupal J; Krechler T; Ák A
Cancer Biomark; 2016 Jun; 17(1):55-65. PubMed ID: 27314293
[TBL] [Abstract][Full Text] [Related]
6. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
[TBL] [Abstract][Full Text] [Related]
7. Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus.
Kolb A; Rieder S; Born D; Giese NA; Giese T; Rudofsky G; Werner J; Büchler MW; Friess H; Esposito I; Kleeff J
Cancer Biol Ther; 2009 Aug; 8(16):1527-33. PubMed ID: 19571666
[TBL] [Abstract][Full Text] [Related]
8. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma.
Gao W; Zhou Y; Li Q; Zhou Q; Tan L; Song Y; Zhao X; Yu M; Zheng S; Ye H; Zeng B; Lin Q; Zhou J; Liu Y; Huang H; Zhang H; Hu X; Li Z; Dai X; Chen R
Diabetologia; 2015 Apr; 58(4):835-44. PubMed ID: 25636208
[TBL] [Abstract][Full Text] [Related]
9. Correlation between exocrine pancreatic secretion and serum concentration of human pancreatic polypeptide in chronic pancreatitis.
Andersen BN; Hagen C; Klein HC; Stadil F; Worning H
Scand J Gastroenterol; 1980; 15(6):699-704. PubMed ID: 7209380
[TBL] [Abstract][Full Text] [Related]
10. Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitis.
Maekawa T; Kamada Y; Ebisutani Y; Ueda M; Hata T; Kawamoto K; Takamatsu S; Mizutani K; Shimomura M; Sobajima T; Fujii H; Nakayama K; Nishino K; Yamada M; Kumada T; Ito T; Eguchi H; Nagano H; Miyoshi E
World J Gastroenterol; 2016 May; 22(17):4403-10. PubMed ID: 27158210
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic polypeptide response to a mixed meal is blunted in pancreatic head cancer associated with diabetes mellitus.
Hart PA; Baichoo E; Bi Y; Hinton A; Kudva YC; Chari ST
Pancreatology; 2015; 15(2):162-6. PubMed ID: 25766398
[TBL] [Abstract][Full Text] [Related]
12. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.
Andersen DK; Andren-Sandberg Å; Duell EJ; Goggins M; Korc M; Petersen GM; Smith JP; Whitcomb DC
Pancreas; 2013 Nov; 42(8):1227-37. PubMed ID: 24152948
[TBL] [Abstract][Full Text] [Related]
13. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma.
Khan IA; Rashid S; Singh N; Rashid S; Singh V; Gunjan D; Das P; Dash NR; Pandey RM; Chauhan SS; Gupta S; Saraya A
Sci Rep; 2021 Feb; 11(1):2824. PubMed ID: 33531550
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.
Singh N; Rashid S; Rashid S; Dash NR; Gupta S; Saraya A
J Cancer Res Clin Oncol; 2020 Apr; 146(4):897-907. PubMed ID: 32146565
[TBL] [Abstract][Full Text] [Related]
15. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.
Prokopchuk O; Grünwald B; Nitsche U; Jäger C; Prokopchuk OL; Schubert EC; Friess H; Martignoni ME; Krüger A
BMC Cancer; 2018 Feb; 18(1):128. PubMed ID: 29394913
[TBL] [Abstract][Full Text] [Related]
16. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
17. Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma.
Poruk KE; Firpo MA; Huerter LM; Scaife CL; Emerson LL; Boucher KM; Jones KA; Mulvihill SJ
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2605-10. PubMed ID: 20729288
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
[TBL] [Abstract][Full Text] [Related]
19. Are elevated pancreatic polypeptide levels in patients with insulinoma secondary to hypoglycaemia?
Nelson RL; Service FJ; Ilstrup DM; Go VL
Lancet; 1980 Sep; 2(8196):659-61. PubMed ID: 6106782
[TBL] [Abstract][Full Text] [Related]
20. Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma.
Poruk KE; Firpo MA; Scaife CL; Adler DG; Emerson LL; Boucher KM; Mulvihill SJ
Pancreas; 2013 Mar; 42(2):193-7. PubMed ID: 23407481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
